Welcome to the ADHD Clinic at UNCG

ACCESS

accessACCESS (Accessing Campus Connections and Empowering Student Success) is a program designed to give undergraduate students with Attention-Deficit/Hyperactivity Disorder (ADHD) the knowledge and skills to be successful academically, personally, and socially. The ACCESS program is currently being offered to UNCG students as part of a clinical research project funded by a 4-year IES grant from the US Department of Education. Entitled “Improving the Educational and Social-Emotional Functioning of College Students with ADHD,” this clinical research project involves evaluating ACCESS through a randomized controlled trial. The project is being conducted at UNCG under the direction of Dr. Arthur D. Anastopoulos (Principal Investigator) and Dr. Joshua Langberg (Co-Principal Investigator) at Virginia Commonwealth University.

Students in ACCESS receive 8 weeks of group-administered cognitive behavioral therapy (CBT) plus 10 sessions of individual mentoring during their first semester in the program. The CBT group is designed to increase accurate knowledge of ADHD and dispel myths, teach behavioral strategies for coping with ADHD symptoms and succeeding in college (e.g., using a planner, improving organization, studying effectively), and increase adaptive thinking. Mentoring is designed to help students apply what they learned in the CBT group, connect students with campus resources, and provide support and coaching. In their second semester, students continue to meet with their mentors and are encouraged to attend a group booster session.

The ACCESS program was developed and refined over the past 4 years as part of the College STAR Project.  College STAR (Supporting Transition Access and Retention) is a grant-funded UNC System initiative supporting students with learning differences.  In the College STAR Project, UNCG partnered with East Carolina University and Appalachian State University to develop programs to help our campuses become more supportive for students with learning differences such as ADHD, Specific Learning Disorders, or executive functioning difficulties. Eighty-eight UNCG students participated in the open clinical trial of ACCESS. The work was made possible by generous funding from the Oak Foundation, the North Carolina GlaxoSmithKline Foundation, and a coalition of Greensboro-area foundations including the Joseph M. Bryan Foundation, the Cemala Foundation, the Weaver Foundation, the Tannenbaum-Sternberger Foundation, and the Michel Family Foundation.